We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Novel MRI Scoring System Helps Avoid Unnecessary Biopsy of Osseous Lesions

By MedImaging International staff writers
Posted on 05 Aug 2024
Print article
Image: The novel MRI scoring system can assess osseous malignancy in soft tissue sarcoma patients following radiotherapy (Photo courtesy of 123RF)
Image: The novel MRI scoring system can assess osseous malignancy in soft tissue sarcoma patients following radiotherapy (Photo courtesy of 123RF)

Soft tissue sarcomas (STS) are rare, malignant tumors that often require a combination of radiotherapy and surgical resection for both pre-operative and post-operative management. Despite advancements in radiotherapy that allow for more targeted radiation fields, the adjacent bone may still be exposed and develop changes such as radiation osteitis. These changes are often detected on magnetic resonance imaging (MRI) but can be challenging to differentiate from potentially malignant lesions. Although biopsies are definitive in distinguishing radiation osteitis from malignancy, they are invasive, expensive, and can cause significant psychological stress for patients while they await results. Therefore, developing an MRI scoring system to identify benign characteristics of radiation osteitis is crucial to avoid unnecessary biopsies.

Researchers at Rush University Medical Center (Chicago, IL, USA) have now developed an innovative MRI scoring system designed to evaluate osseous lesions and predict the potential for malignancy based on MRI scores in STS patients who have undergone radiotherapy. This scoring system, which demonstrates high interobserver reliability, is designed to be simple for clinical application, aiding clinicians in deciding whether a biopsy is necessary for concerning osseous lesions in patients with a history of radiotherapy. The MRI scoring system includes three parameters: morphology, signal intensity, and progression. The interobserver reliability of the MRI scores was analyzed using Cohen’s kappa coefficient, and Receiver operating curve (ROC) analysis was conducted to establish a predictive MRI score for malignancy.

In a retrospective review of 156 MRIs from 30 STS patients who had received radiotherapy, the study, which was published in the European Journal of Radiology, found that two patients (6.7%) developed regional osseous metastasis detectable on MRI. The kappa coefficient for the scoring system was 0.785, indicating substantial interobserver agreement (p < 0.001). The ROC analysis indicated that the optimal cutoff value for a malignant lesion on MRI was 5.5 (area under the curve 0.998; p < 0.001). This novel MRI scoring system recommends that lesions scoring six or above should be biopsied to confirm whether malignancy is present. These findings suggest that the scoring system could be effectively used by multidisciplinary care teams to provide clinical recommendations for patients with STS, helping to differentiate between concerns of malignancy and radiation-induced changes on MRI.

Ultrasound Scanner
TBP-5533
Opaque X-Ray Mobile Lead Barrier
2594M
New
Digital X-Ray Detector Panel
Acuity G4
New
X-ray Diagnostic System
FDX Visionary-A

Print article

Channels

Ultrasound

view channel
Image: Breast ultrasound provides an alternative screening modality to mammography in low-resource settings (Photo courtesy of 123RF)

Automated Breast Ultrasound Provides Alternative to Mammography in Low-Resource Settings

China has faced significant challenges in implementing a population-based mammographic screening program, primarily due to a shortage of breast radiologists and issues with screening quality.... Read more

Nuclear Medicine

view channel
Image: PSMA-PET/CT images of an 85-year-old patient with hormone-sensitive prostate cancer (Photo courtesy of Dr. Adrien Holzgreve)

Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients

Prostate-specific membrane antigen–portron emission tomography (PSMA-PET) imaging has become an essential tool in transforming the way prostate cancer is staged. Using small amounts of radioactive “tracers,”... Read more

General/Advanced Imaging

view channel
Image: Automated methods enable the analysis of PET/CT scans (left) to accurately predict tumor location and size (right) (Photo courtesy of Nature Machine Intelligence, 2024. DOI: 10.1038/s42256-024-00912-9)

Deep Learning Based Algorithms Improve Tumor Detection in PET/CT Scans

Imaging techniques are essential for cancer diagnosis, as accurately determining the location, size, and type of tumors is critical for selecting the appropriate treatment. The key imaging methods include... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.